Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 1 | Environmental Health

Fig. 1

From: Per- and polyfluoroalkyl substances, apolipoproteins and the risk of coronary heart disease in US men and women

Fig. 1

Dose–response associations of plasma total PFOS, branched PFOS and linear PFOS with the risk of CHD. Note: This analysis was run in the case–control cohort based on conditional logistic regression. The models were adjusted for matching factors (including age, gender, smoking status and date of blood sampling), fasting status (yes or no), BMI (kg/m2), physical activity (MET-hr/wk), alcohol consumption (never, 0–4.9 g/d, 5.0–14.9 g/d, and > 15 g/d), AHEI (continuous), aspirin use (yes or no), regular lipid-lowering medication use (yes or no), family history of MI (yes or no), and history of hypertension (yes or no), diabetes (yes or no) and hypercholesterolemia (yes or no). The x-axis is natural log-transformed total PFOS, brPFOS and nPFOS, respectively; the y-axis represents the hazard ratio of CHD. The lines in the plot show the trend for the association of interest and p-values are showed on the top-left; the shade denotes 95% confidence interval. Abbreviations: PFOS, Perfluorooctane sulfonate; brPFOS, branched PFOS; nPFOS, linear PFOS

Back to article page

Environmental Health

ISSN: 1476-069X